Cargando…

Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women

Detalles Bibliográficos
Autores principales:	Evans, D. Gareth, Wisely, Julie, Clancy, Tara, Lalloo, Fiona, Wilson, Mary, Johnson, Richard, Duncan, Jonathon, Barr, Lester, Gandhi, Ashu, Howell, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659163/ https://www.ncbi.nlm.nih.gov/pubmed/26603733 http://dx.doi.org/10.1186/s13058-015-0650-8

Ejemplares similares

The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer
por: Basu, Narendra Nath, et al.
Publicado: (2021)

The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers
por: Grossman, Sharon Galper
Publicado: (2015)

Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect
por: Liede, Alexander, et al.
Publicado: (2018)

Celebrity disclosures and information seeking: The case of Angelina Jolie
por: Juthe, Robin H., et al.
Publicado: (2014)

Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie’s New York Times editorial
por: Desai, Sunita, et al.
Publicado: (2016)

Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer
por: Evans, D.Gareth, et al.
Publicado: (2021)

The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services
por: Evans, D Gareth R, et al.
Publicado: (2014)

Influence of the Angelina Jolie Announcement and Insurance Reimbursement on Practice Patterns for Hereditary Breast Cancer
por: Lee, Jihyoun, et al.
Publicado: (2017)

Familial breast cancer: Genetic counseling over time, including patients´ expectations and initiators considering the Angelina Jolie effect
por: Evers, Christina, et al.
Publicado: (2017)

Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect”
por: Staudigl, Christine, et al.
Publicado: (2016)

Consumer experiences of shame in clinical encounters for breast cancer treatment. “Who do you think you are– Angelina Jolie?”
por: Brennan, M.E., et al.
Publicado: (2023)

Angelina
por: Delgado, Rafael, 1853-1914
Publicado: (1947)

Jolis deuils : contes /
por: Carrier, Roch
Publicado: (1982)

Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?
por: Evans, D. Gareth, et al.
Publicado: (2019)

Angelina’s choice
por: Goel, Nishu Singh
Publicado: (2013)

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010)

Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?
por: Prosperi, Mattia CF, et al.
Publicado: (2014)

Experience with Bilateral Risk-Reducing Mastectomy for an Unaffected BRCA Mutation Carrier
por: Maeshima, Yurina, et al.
Publicado: (2016)

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
por: Heemskerk-Gerritsen, Bernadette A. M., et al.
Publicado: (2019)

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
por: Antoniou, Antonis C, et al.
Publicado: (2006)

Commentary: Bilateral risk-reducing mastectomy is the safest strategy in BRCA1 carriers
por: Glassey, Rachael, et al.
Publicado: (2017)

Angelina o un drama en 1880
por: Jardiel Poncela, Enrique, 1901-1952
Publicado: (1942)

Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation
por: Jung, Sung Mi, et al.
Publicado: (2020)

The Importance of Risk-Reducing Prophylactic Mastectomy in Breast Cancer (BRCA) Carriers: A Case Report
por: Ochaney, Priyanka, et al.
Publicado: (2019)

Análisis narratológico de Angelina de Rafael Delgado
por: Cabral Sanguino, Adán
Publicado: (1997)

Contralateral risk reducing mastectomy in Non-BRCA-Mutated patients
por: Falco, Giuseppe, et al.
Publicado: (2016)

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
por: van Sprundel, T C, et al.
Publicado: (2005)

BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort study
por: Kitson, Sarah J., et al.
Publicado: (2020)

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
por: Evans, D Gareth, et al.
Publicado: (2008)

Counterpoint: Angelina's choice-or the choice of anyone else in her place
por: Parikh, P. M.
Publicado: (2014)

Ablatio mammae like Angelina: Fad or a wise decision?
por: Aggarwal, Himanshi, et al.
Publicado: (2015)

Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women
por: Evans, D. Gareth, et al.
Publicado: (2021)

Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy
por: Schmidt, MK, et al.
Publicado: (2005)

Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers
por: Evans, DG, et al.
Publicado: (2017)

Nipple Sparing Mastectomy as a Risk-Reducing Procedure for BRCA-Mutated Patients
por: Rocco, Nicola, et al.
Publicado: (2021)

Time to decide about risk-reducing mastectomy: A case series of BRCA1/2 gene mutation carriers
por: McCullum, Mary, et al.
Publicado: (2007)

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
por: Metcalfe, Kelly, et al.
Publicado: (2014)

Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987–2020)
por: Howell, Anthony, et al.
Publicado: (2020)

Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women
por: Sidon, L, et al.
Publicado: (2012)

Implant-Based Breast Reconstruction after Risk-Reducing Mastectomy in BRCA Mutation Carriers: A Single-Center Retrospective Study
por: Cammarata, Emanuele, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_amb8snb98gejflb3fopl0k1r2a